Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page
- Check6 days agoChange DetectedNo additions or deletions are present for this page in the provided data. There are no content changes to interpret.SummaryDifference0.1%

- Check13 days agoChange DetectedNo changes are recorded for this page; the displayed study details remain the same based on the provided data.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.6.3 was added and Revision: v3.6.0 was removed, indicating an updated version tag for the page. This reflects an administrative update to the page's revision history rather than changes to study content.SummaryDifference0.1%

- Check42 days agoChange DetectedRecruitment is now listed as No longer looking for participants, indicating enrollment has ended. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label formatting along with a revision note to reflect documentation improvements.SummaryDifference0.5%

- Check49 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the prior v3.5.4. This reflects a minor update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a metadata-only update to the page. No substantive study content or functionality changes are indicated.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.